Skip to main content
Erschienen in: European Journal of Pediatrics 10/2012

01.10.2012 | Review

Monogenic forms of hypertension

verfasst von: Giacomo Domenico Simonetti, Markus G. Mohaupt, Mario G. Bianchetti

Erschienen in: European Journal of Pediatrics | Ausgabe 10/2012

Einloggen, um Zugang zu erhalten

Abstract

Arterial hypertension in childhood is less frequent as compared to adulthood but is more likely to be secondary to an underlying disorder. After ruling out more obvious causes, some patients still present with strongly suspected secondary hypertension of yet unknown etiology. A number of these children have hypertension due to single gene mutations inherited in an autosomal dominant or recessive fashion. The finding of abnormal potassium levels (low or high) in the presence of suppressed renin secretion, and metabolic alkalosis or acidosis should prompt consideration of these familial diseases. However, mild hypertension and the absence of electrolyte abnormalities do not exclude hereditary conditions. In monogenic hypertensive disorders, three distinct mechanisms leading to the common final pathway of increased sodium reabsorption, volume expansion, and low plasma renin activity are documented. The first mechanism relates to gain-of-function mutations with a subsequent hyperactivity of renal sodium and chloride reabsorption leading to plasma volume expansion (e.g., Liddle's syndrome, Gordon's syndrome). The second mechanism involves deficiencies of enzymes that regulate adrenal steroid hormone synthesis and deactivation (e.g., subtypes of congenital adrenal hyperplasia, apparent mineralocorticoid excess (AME)). The third mechanism is characterized by excessive aldosterone synthesis that escapes normal regulatory mechanisms and leading to volume-dependent hypertension in the presence of suppressed renin release (glucocorticoid remediable aldosteronism). Hormonal studies coupled with genetic testing can help in the early diagnosis of these disorders.
Literatur
1.
Zurück zum Zitat Dave-Sharma S, Wilson RC, Harbison MD et al (1998) Examination of genotype and phenotype relationships in 14 patients with apparent mineralocorticoid excess. J Clin Endocrinol Metab 83:2244–2254PubMedCrossRef Dave-Sharma S, Wilson RC, Harbison MD et al (1998) Examination of genotype and phenotype relationships in 14 patients with apparent mineralocorticoid excess. J Clin Endocrinol Metab 83:2244–2254PubMedCrossRef
2.
Zurück zum Zitat Dluhy RG, Lifton RP (1995) Glucocorticoid-remediable aldosteronism (GRA): diagnosis, variability of phenotype and regulation of potassium homeostasis. Steroids 60:48–51PubMedCrossRef Dluhy RG, Lifton RP (1995) Glucocorticoid-remediable aldosteronism (GRA): diagnosis, variability of phenotype and regulation of potassium homeostasis. Steroids 60:48–51PubMedCrossRef
3.
Zurück zum Zitat Ferrari P, Lovati E, Frey FJ (2000) The role of the 11beta-hydroxysteroid dehydrogenase type 2 in human hypertension. J Hypertens 18:241–248PubMedCrossRef Ferrari P, Lovati E, Frey FJ (2000) The role of the 11beta-hydroxysteroid dehydrogenase type 2 in human hypertension. J Hypertens 18:241–248PubMedCrossRef
4.
Zurück zum Zitat Findling JW, Raff H, Hansson JH et al (1997) Liddle's syndrome: prospective genetic screening and suppressed aldosterone secretion in an extended kindred. J Clin Endocrinol Metab 82:1071–1074PubMedCrossRef Findling JW, Raff H, Hansson JH et al (1997) Liddle's syndrome: prospective genetic screening and suppressed aldosterone secretion in an extended kindred. J Clin Endocrinol Metab 82:1071–1074PubMedCrossRef
5.
Zurück zum Zitat Gordon RD (1986) Syndrome of hypertension and hyperkalemia with normal glomerular filtration rate. Hypertension 8:93–102PubMedCrossRef Gordon RD (1986) Syndrome of hypertension and hyperkalemia with normal glomerular filtration rate. Hypertension 8:93–102PubMedCrossRef
6.
Zurück zum Zitat Gordon RD, Geddes RA, Pawsey CG et al (1970) Hypertension and severe hyperkalaemia associated with suppression of renin and aldosterone and completely reversed by dietary sodium restriction. Australas Ann Med 19:287–294PubMed Gordon RD, Geddes RA, Pawsey CG et al (1970) Hypertension and severe hyperkalaemia associated with suppression of renin and aldosterone and completely reversed by dietary sodium restriction. Australas Ann Med 19:287–294PubMed
7.
Zurück zum Zitat Guyton AC, Coleman TG, Cowley AV Jr et al (1972) Arterial pressure regulation. Overriding dominance of the kidneys in long-term regulation and in hypertension. Am J Med 52:584–594PubMedCrossRef Guyton AC, Coleman TG, Cowley AV Jr et al (1972) Arterial pressure regulation. Overriding dominance of the kidneys in long-term regulation and in hypertension. Am J Med 52:584–594PubMedCrossRef
8.
Zurück zum Zitat Lifton RP, Dluhy RG, Powers M et al (1992) A chimaeric 11 beta-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature 355:262–265PubMedCrossRef Lifton RP, Dluhy RG, Powers M et al (1992) A chimaeric 11 beta-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature 355:262–265PubMedCrossRef
9.
Zurück zum Zitat Litchfield WR, Anderson BF, Weiss RJ et al (1998) Intracranial aneurysm and hemorrhagic stroke in glucocorticoid-remediable aldosteronism. Hypertension 31:445–450PubMedCrossRef Litchfield WR, Anderson BF, Weiss RJ et al (1998) Intracranial aneurysm and hemorrhagic stroke in glucocorticoid-remediable aldosteronism. Hypertension 31:445–450PubMedCrossRef
10.
Zurück zum Zitat Lurbe E, Cifkova R, Cruickshank JK et al (2009) Management of high blood pressure in children and adolescents: recommendations of the European Society of Hypertension. J Hypertens 27:1719–1742PubMedCrossRef Lurbe E, Cifkova R, Cruickshank JK et al (2009) Management of high blood pressure in children and adolescents: recommendations of the European Society of Hypertension. J Hypertens 27:1719–1742PubMedCrossRef
11.
Zurück zum Zitat Martinez-Aguayo A, Aglony M, Campino C et al (2010) Aldosterone, plasma renin activity, and aldosterone/renin ratio in a normotensive healthy pediatric population. Hypertension 56:391–396PubMedCrossRef Martinez-Aguayo A, Aglony M, Campino C et al (2010) Aldosterone, plasma renin activity, and aldosterone/renin ratio in a normotensive healthy pediatric population. Hypertension 56:391–396PubMedCrossRef
12.
Zurück zum Zitat Milford DV (1999) Investigation of hypertension and the recognition of monogenic hypertension. Arch Dis Child 81:452–455PubMedCrossRef Milford DV (1999) Investigation of hypertension and the recognition of monogenic hypertension. Arch Dis Child 81:452–455PubMedCrossRef
13.
Zurück zum Zitat Morineau G, Sulmont V, Salomon R et al (2006) Apparent mineralocorticoid excess: report of six new cases and extensive personal experience. J Am Soc Nephrol 17:3176–3184PubMedCrossRef Morineau G, Sulmont V, Salomon R et al (2006) Apparent mineralocorticoid excess: report of six new cases and extensive personal experience. J Am Soc Nephrol 17:3176–3184PubMedCrossRef
14.
Zurück zum Zitat National high blood pressure education program working group on high blood pressure in children and adolescents (2004) The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 114:555–576CrossRef National high blood pressure education program working group on high blood pressure in children and adolescents (2004) The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 114:555–576CrossRef
15.
Zurück zum Zitat Nunez BS, Rogerson FM, Mune T et al (1999) Mutants of 11beta-hydroxysteroid dehydrogenase (11-hsd2) with partial activity: improved correlations between genotype and biochemical phenotype in apparent mineralocorticoid excess. Hypertension 34:638–642PubMedCrossRef Nunez BS, Rogerson FM, Mune T et al (1999) Mutants of 11beta-hydroxysteroid dehydrogenase (11-hsd2) with partial activity: improved correlations between genotype and biochemical phenotype in apparent mineralocorticoid excess. Hypertension 34:638–642PubMedCrossRef
16.
Zurück zum Zitat Rodriguez-Soriano J, Vallo A (1988) Renal tubular hyperkalaemia in childhood. Pediatr Nephrol (Berlin, Germany) 2:498–509CrossRef Rodriguez-Soriano J, Vallo A (1988) Renal tubular hyperkalaemia in childhood. Pediatr Nephrol (Berlin, Germany) 2:498–509CrossRef
17.
Zurück zum Zitat Shimkets RA, Warnock DG, Bositis CM et al (1994) Liddle's syndrome: heritable human hypertension caused by mutations in the beta subunit of the epithelial sodium channel. Cell 79:407–414PubMedCrossRef Shimkets RA, Warnock DG, Bositis CM et al (1994) Liddle's syndrome: heritable human hypertension caused by mutations in the beta subunit of the epithelial sodium channel. Cell 79:407–414PubMedCrossRef
18.
Zurück zum Zitat Spitzer A, Edelmann CM Jr, Goldberg LD et al (1973) Short stature, hyperkalemia and acidosis: a defect in renal transport of potassium. Kidney Int 3:251–257PubMedCrossRef Spitzer A, Edelmann CM Jr, Goldberg LD et al (1973) Short stature, hyperkalemia and acidosis: a defect in renal transport of potassium. Kidney Int 3:251–257PubMedCrossRef
19.
Zurück zum Zitat Stowasser M, Bachmann AW, Huggard PR et al (2000) Treatment of familial hyperaldosteronism type I: only partial suppression of adrenocorticotropin required to correct hypertension. J Clin Endocrinol Metab 85:3313–3318PubMedCrossRef Stowasser M, Bachmann AW, Huggard PR et al (2000) Treatment of familial hyperaldosteronism type I: only partial suppression of adrenocorticotropin required to correct hypertension. J Clin Endocrinol Metab 85:3313–3318PubMedCrossRef
20.
Zurück zum Zitat Vehaskari VM (2009) Heritable forms of hypertension. Pediatr Nephrol (Berlin, Germany) 24:1929–1937CrossRef Vehaskari VM (2009) Heritable forms of hypertension. Pediatr Nephrol (Berlin, Germany) 24:1929–1937CrossRef
21.
Zurück zum Zitat Wilson RC, Krozowski ZS, Li K et al (1995) A mutation in the hsd11b2 gene in a family with apparent mineralocorticoid excess. J Clin Endocrinol Metab 80:2263–2266PubMedCrossRef Wilson RC, Krozowski ZS, Li K et al (1995) A mutation in the hsd11b2 gene in a family with apparent mineralocorticoid excess. J Clin Endocrinol Metab 80:2263–2266PubMedCrossRef
22.
Zurück zum Zitat Yang CL, Angell J, Mitchell R et al (2003) Wnk kinases regulate thiazide-sensitive Na-Cl cotransport. J Clin Investig 111:1039–1045PubMed Yang CL, Angell J, Mitchell R et al (2003) Wnk kinases regulate thiazide-sensitive Na-Cl cotransport. J Clin Investig 111:1039–1045PubMed
Metadaten
Titel
Monogenic forms of hypertension
verfasst von
Giacomo Domenico Simonetti
Markus G. Mohaupt
Mario G. Bianchetti
Publikationsdatum
01.10.2012
Verlag
Springer-Verlag
Erschienen in
European Journal of Pediatrics / Ausgabe 10/2012
Print ISSN: 0340-6199
Elektronische ISSN: 1432-1076
DOI
https://doi.org/10.1007/s00431-011-1440-7

Weitere Artikel der Ausgabe 10/2012

European Journal of Pediatrics 10/2012 Zur Ausgabe

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Erstmanifestation eines Diabetes-Typ-1 bei Kindern: Ein Notfall!

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Manifestiert sich ein Typ-1-Diabetes bei Kindern, ist das ein Notfall – ebenso wie eine diabetische Ketoazidose. Die Grundsäulen der Therapie bestehen aus Rehydratation, Insulin und Kaliumgabe. Insulin ist das Medikament der Wahl zur Behandlung der Ketoazidose.

Frühe Hypertonie erhöht späteres kardiovaskuläres Risiko

Wie wichtig es ist, pädiatrische Patienten auf Bluthochdruck zu screenen, zeigt eine kanadische Studie: Hypertone Druckwerte in Kindheit und Jugend steigern das Risiko für spätere kardiovaskuläre Komplikationen.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.